David joined Syngenta Ventures in 2012. Prior to this he was a Partner for seven years at Intersouth Partners, a traditional venture capital firm located in Durham, NC, which has invested in more than 100 private companies and manages $780 million in seven venture capital limited partnerships. While at Intersouth Partners, David focused on making venture capital investments in early stage pharmaceutical, biotechnology, medical device, and healthcare information technology companies. Prior to entering the venture capital field, David held numerous senior management level positions in pharmaceutical marketing, sales, and new product commercialization at Johnson & Johnson and Pharmacia Corporation. David has extensive experience with in-licensing and mergers and acquisitions.
He has served on the boards of numerous privately held companies, foundations and entrepreneurship organizations. Currently he is serving as a director on the Board of Metabolon and an observer on the Board of Illumitex as well as an undisclosed investment.
David holds a B.S. in Engineering with a concentration in International Security Studies from The United States Military Academy at West Point and an M.B.A. from Duke University.